Drug
6% Hydroxyethyl Starch 130/0.4
6% Hydroxyethyl Starch 130/0.4 is a pharmaceutical drug with 5 clinical trials. Historical success rate of 80.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
80.0%
Based on 4 completed trials
Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(20%)
Phase Distribution
Ph not_applicable
1
20%
Ph phase_3
4
80%
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution5 total trials
Phase 3Large-scale testing
4(80.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
80.0%
4 of 5 finished
Non-Completion Rate
20.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(4)
Terminated(1)
Detailed Status
Completed4
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
80.0%
Most Advanced
Phase 3
Trials by Phase
Phase 34 (80.0%)
N/A1 (20.0%)
Trials by Status
completed480%
terminated120%
Recent Activity
0 active trials
Showing 5 of 5
terminatednot_applicable
Starch or Saline After Cardiac Surgery
NCT00964015
completedphase_3
Comparison of Hemodynamic Effects of Two Colloid Therapies in Post-operative Patients Undergoing Pancreaticoduodenectomy
NCT01758172
completedphase_3
Crystalloid Versus Hydroxyethyl Starch Trials
NCT00935168
completedphase_3
Scandinavian Starch for Severe Sepsis/Septic Shock Trial
NCT00962156
completedphase_3
Trial of 6% HES130/0.4
NCT01010022
Clinical Trials (5)
Showing 5 of 5 trials
NCT00964015Not Applicable
Starch or Saline After Cardiac Surgery
NCT01758172Phase 3
Comparison of Hemodynamic Effects of Two Colloid Therapies in Post-operative Patients Undergoing Pancreaticoduodenectomy
NCT00935168Phase 3
Crystalloid Versus Hydroxyethyl Starch Trials
NCT00962156Phase 3
Scandinavian Starch for Severe Sepsis/Septic Shock Trial
NCT01010022Phase 3
Trial of 6% HES130/0.4
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5